Thomas Kearney, PharmD

Associate Dean

Department of Clinical Pharmacy

[email protected]

Phone: +1 415 502-2882

Fax: +1 415 502-6012

513 Parnassus Avenue, Rm 124

UCSF Box 0403

San Francisco, CA 94143

United States

Links

California Poison Control Center

UCSF Profiles

Educational programs

PharmD Degree Program

UCSF centers, institutes, and research programs

Managing Director, San Francisco Division, California Poison Control System (CPCS)

External affiliations

Associate Editor, Poisoning and Drug Overdose

What I do

As Associate Dean of Academic Affairs, I represent the Dean’s Office and provide guidance, assessment, and action on all issues related to policies and procedures for academic affairs. The primary duties cover the following that concern faculty at the SOP: Appointment and advancement; Compensation and benefits; Problem resolution; Adherence to UC system-wide and campus policy and procedures; and Liaison to the UCSF Vice-provost office of Academic Affairs. As the Managing Director of the SF Division of the California Poison Control System, I have administrative responsibilities for professional services provided by the poison center hotline (hiring, training, evaluation, and QA for pharmacy staff) and implementation (at the SF site). I also serve as the attending for hospital consultations one day per week with oversight of clerkship students and medical toxicology fellows.

Departmental research area

clinical research

My research expertise

Clinical toxicology, Antidotes for poisoning, Pharmacoepidemiology, Poison center operations

Clinical expertise

clinical toxicology

Degrees

PharmD, University of California, San Francisco, 1980

Biography

Professor of Clinical Pharmacy at the University of California, San Francisco, Managing Director of the San Francisco Division of the California Poison Control System, and completed a one-year mid-career fellowship (Institute for Health Policy Studies, Institute for Health and Aging and Health Research Training Program, UCSF School of Medicine) in health services research. Dr. Kearney is a graduate of the University of California School of Pharmacy. He completed a Residency in Hospital Pharmacy at the University of Michigan and a two-year post-doctoral fellowship in clinical toxicology at University of California, San Diego and San Francisco. He has served as Associate Director of the Louisiana State Regional Poison Control Center and the Executive Director of the Delaware Valley Regional Poison Center at Children's Hospital of Philadelphia. He has served in leadership positions in the American Association of Poison Control Centers (Treasurer) and is a Diplomate and past-President of the Board of the American Board of Applied Toxicology. He has presented 61 scientific papers and has published 33 peer-reviewed journal articles and 15 book chapters on poisoning-related topics. He serves as a reviewer for 8 medical journals and as the associate editor for the publication: Poisoning and Drug Overdose - a Lange clinical manual, Appleton and Lange publishers.

Research keywords

pharmacoepidemiology, antidotes for poisoning, poison center operations, clinical toxicology, Hemofiltration, poisoning, Drug-Related Side Effects and Adverse Reactions, Poison Control Centers, Drug Overdose

Licensure and certifications

Licentiate in Pharmacy, California, 1980

Diplomate, American Board of Applied Toxicology, 1991 -

News

Publications

Smollin CG, Petrie MS, Kearney T. Carbamazepine and carbamazepine-10,11-epoxide clearance measurements during continuous venovenous hemofiltration in a massive overdose. Clin Toxicol (Phila). 2016 Jun; 54(5):424-7.

Tsutaoka BT, Ho RY, Fung SM, Kearney TE. Comparative Toxicity of Tapentadol and Tramadol Utilizing Data Reported to the National Poison Data System. Ann Pharmacother. 2015 Dec; 49(12):1311-6.

Wu AH, Hamilton R, Middleberg R, Kacinko S, Kearney T. Investigation of postmortem absorption and redistribution after the application of a fentanyl patch. J Forensic Sci. 2015 Mar; 60(2):532-5.

Al-Abri SA, Woodburn C, Olson KR, Kearney TE. Ventricular dysrhythmias associated with poisoning and drug overdose: a 10-year review of statewide poison control center data from California. Am J Cardiovasc Drugs. 2015 Feb; 15(1):43-50.

Kearney T, Hiatt P, Birdsall E, Smollin C. Pepper spray injury severity: ten-year case experience of a poison control system. Prehosp Emerg Care. 2014 Jul-Sep; 18(3):381-6.

Lung DD, Kearney TE, Brasiel JA, Olson KR. Predictors of Death and Prolonged Renal Insufficiency in Ethylene Glycol Poisoning. J Intensive Care Med. 2015 Jul; 30(5):270-7.

Kearney TE, Lieu D, Singer N, Tsutaoka B, Ho R, Olson K. Investigating the reliability of substance toxicity information found on the Internet in pediatric poisonings. Pediatr Emerg Care. 2013 Dec; 29(12):1249-54.

Wu AH, Kearney T. Lack of impairment due to confirmed codeine use prior to a motor vehicle accident: role of pharmacogenomics. J Forensic Leg Med. 2013 Nov; 20(8):1024-7.

Thundiyil JG, Rowley F, Papa L, Olson KR, Kearney TE. Risk factors for complications of drug-induced seizures. J Med Toxicol. 2011 Mar; 7(1):16-23.

Kim-Katz SY, Anderson IB, Kearney TE, MacDougall C, Hudmon KS, Blanc PD. Topical antacid therapy for capsaicin-induced dermal pain: a poison center telephone-directed study. Am J Emerg Med. 2010 Jun; 28(5):596-602.

Kearney T, Tu N, Haller C. Adverse drug events associated with yohimbine-containing products: a retrospective review of the California Poison Control System reported cases. Ann Pharmacother. 2010 Jun; 44(6):1022-9.

Ciranni MA, Kearney TE, Olson KR. Comparing acute toxicity of first- and second-generation antipsychotic drugs: a 10-year, retrospective cohort study. J Clin Psychiatry. 2009 Jan; 70(1):122-9.

Thundiyil JG, Kearney TE, Olson KR. Evolving epidemiology of drug-induced seizures reported to a Poison Control Center System. J Med Toxicol. 2007 Mar; 3(1):15-9.

Haffty BG, Yang Q, Reiss M, Kearney T, Higgins SA, Weidhaas J, Harris L, Hait W, Toppmeyer D. Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer. J Clin Oncol. 2006 Dec 20; 24(36):5652-7.

Kearney TE, Van Bebber SL, Hiatt PH, Olson KR. Protocols for pediatric poisonings from nontoxic substances: are they valid? Pediatr Emerg Care. 2006 Apr; 22(4):215-21.

Bash-Babula J, Toppmeyer D, Labassi M, Reidy J, Orlick M, Senzon R, Alli E, Kearney T, August D, Shih W, Yang JM, Hait WN. A Phase I/pilot study of sequential doxorubicin/vinorelbine: effects on p53 and microtubule-associated protein 4. Clin Cancer Res. 2002 May; 8(5):1057-64.

Search form